AMGN
Amgen
Health Care
Biotechnology
Thousand Oaks, California
Last filing: Feb 13, 2026 (FY2025)
Balance Sheet 11 Accounts • 5 Years
| Account | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| BS_Assets_ShortTermInvest | $0 | $0 | $0 | $1.7B | $48.0M |
| BS_Assets_Inventory | $0 | $7.0B | $9.5B | $4.9B | $4.1B |
| BS_Assets_PPE | $0 | $6.5B | $5.9B | $5.4B | $5.2B |
| BS_Assets_Goodwill | $0 | $18.6B | $18.6B | $15.5B | $14.9B |
| BS_Assets_IntangibleAssets | $0 | $27.7B | $32.6B | $16.1B | $15.2B |
| BS_Liab_AccruedLiab | $0 | $17.6B | $15.4B | $12.5B | $10.7B |
| BS_Liab_LongTermDebt | $0 | $56.5B | $63.2B | $37.4B | $33.2B |
| BS_Liab_OtherNoncurrent | $0 | $2.3B | $2.3B | $2.7B | $2.5B |
| BS_Equity_PreferredStock | $0 | $0 | $0 | $0 | $0 |
| BS_Equity_CommonStock | $0 | $3.3B | $3.3B | $3.3B | $3.3B |
| BS_Equity_AOCI | $0 | $-66.0M | $-289.0M | $-231.0M | $-796.0M |